ストックスクリーナーアプリを入手
328.80
0.21%
-0.8295
前日終値:
$329.63
開ける：
$328.65
24時間の取引高:
60,246
Relative Volume:
0.02
時価総額：
$176.99B
収益：
$35.89B
当期純損益:
$7.01B
株価収益率:
25.42
EPS:
12.9352
ネットキャッシュフロー:
$11.54B
1週間 パフォーマンス:
-0.77%
1か月 パフォーマンス:
-4.78%
6か月 パフォーマンス:
+17.81%
1年 パフォーマンス:
+26.85%
1日の値動き範囲:
$327.07
$329.37
1週間の範囲:
$327.07
$334.38
52週間の値動き範囲:
$257.05
$346.38
Amgen Inc Stock (AMGN) Company Profile
AMGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
328.69 | 177.50B | 35.89B | 7.01B | 11.54B | 12.94 |
|
LLY
Lilly Eli Co
|
1,078.70 | 965.48B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
206.98 | 500.07B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
230.93 | 407.98B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
138.96 | 267.10B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
106.55 | 264.63B | 63.90B | 19.05B | 13.05B | 7.5596 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-05 | アップグレード | Erste Group | Hold → Buy |
| 2025-11-24 | 再開されました | Truist | Hold |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-09-03 | 再開されました | Raymond James | Mkt Perform |
| 2025-05-20 | 再開されました | Guggenheim | Neutral |
| 2025-04-22 | 再開されました | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 再開されました | BofA Securities | Underperform |
| 2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
| 2024-11-14 | 開始されました | Citigroup | Neutral |
| 2024-10-17 | 開始されました | Bernstein | Outperform |
| 2024-10-14 | ダウングレード | Truist | Buy → Hold |
| 2024-09-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-08-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | アップグレード | Barclays | Underweight → Equal Weight |
| 2024-05-03 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 再開されました | Raymond James | Mkt Perform |
| 2024-02-07 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-11-02 | アップグレード | Truist | Hold → Buy |
| 2023-10-20 | 再開されました | JP Morgan | Neutral |
| 2023-10-17 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 再開されました | BofA Securities | Neutral |
| 2023-09-06 | 開始されました | HSBC Securities | Buy |
| 2023-04-24 | 繰り返されました | Oppenheimer | Outperform |
| 2023-03-13 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 繰り返されました | Truist | Buy |
| 2022-11-18 | 開始されました | Credit Suisse | Underperform |
| 2022-10-31 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2022-10-11 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 開始されました | SVB Leerink | Mkt Perform |
| 2022-02-09 | 繰り返されました | Barclays | Equal Weight |
| 2022-02-09 | 繰り返されました | Jefferies | Buy |
| 2022-02-09 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 繰り返されました | Oppenheimer | Outperform |
| 2022-02-09 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-12-09 | 再開されました | Wells Fargo | Equal Weight |
| 2021-12-06 | 開始されました | Goldman | Buy |
| 2021-11-19 | 開始されました | BMO Capital Markets | Market Perform |
| 2021-09-23 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 開始されました | Daiwa Securities | Buy |
| 2020-10-28 | 開始されました | UBS | Neutral |
| 2020-10-26 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | アップグレード | Truist | Hold → Buy |
| 2020-10-09 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | ダウングレード | Truist | Buy → Hold |
| 2020-10-08 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 再開されました | Guggenheim | Neutral |
| 2020-03-31 | 開始されました | Wolfe Research | Peer Perform |
| 2020-03-30 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 開始されました | Barclays | Equal Weight |
| 2020-01-31 | ダウングレード | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 開始されました | Raymond James | Mkt Perform |
| 2019-12-17 | 再開されました | Morgan Stanley | Overweight |
| 2019-11-12 | 開始されました | SunTrust | Buy |
| 2019-11-05 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 再開されました | BofA/Merrill | Neutral |
| 2019-08-19 | ダウングレード | Mizuho | Buy → Neutral |
| 2019-05-23 | アップグレード | Citigroup | Neutral → Buy |
すべてを表示
Amgen Inc (AMGN) 最新ニュース
Argus Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - MarketBeat
Argus Adjusts Price Target on Amgen to $360 From $310, Maintains Buy Rating - marketscreener.com
Diversified Trust Co Has $12.05 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
The Truth About Amgen Inc.: Is This Biotech Giant the Next Big Money Gamechanger? - AD HOC NEWS
Amgen Inc.: How a Biotech Veteran Is Rebuilding Its Flagship Pipeline - AD HOC NEWS
Amgen stock slips to $330 as year-end pullback hits Wall Street; Fed minutes and MariTide updates in focus - ts2.tech
Verastem ends trial of Avmapki Fakzynja combo with Amgen's Lumakras in NSCLC - Seeking Alpha
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Amgen Inc. $AMGN Shares Acquired by SS&H Financial Advisors Inc. - MarketBeat
Amgen Inc. Stock (AMGN) Opinions on 2025 Revenue Guidance and Drug Sales - Quiver Quantitative
Amgen Inc. $AMGN Shares Sold by Meyer Handelman Co. - MarketBeat
Carnegie Investment Counsel Has $30.27 Million Stake in Amgen Inc. $AMGN - MarketBeat
Can Amgen Sustain Its Rally In 2026 (NASDAQ:AMGN) - Seeking Alpha
Check out Amgen's stock price (AMGN-CA) in real time - CNBC
Amgen Inc. $AMGN Stake Reduced by Pacer Advisors Inc. - MarketBeat
Avanza Fonder AB Purchases 4,546 Shares of Amgen Inc. $AMGN - MarketBeat
Does FDA’s UPLIZNA gMG Expansion Reshape the Bull Case for Amgen’s Diversification Story (AMGN)? - simplywall.st
Brookstone Capital Management Acquires 16,042 Shares of Amgen Inc. $AMGN - MarketBeat
Farther Finance Advisors LLC Buys 3,158 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Alpine Woods Capital Investors LLC - MarketBeat
Amgen Strikes Drug Pricing Deal With Trump: What Investors Should Know - The Globe and Mail
Swedbank AB Sells 283,479 Shares of Amgen Inc. $AMGN - MarketBeat
Should You Be Excited About Amgen Inc.'s (NASDAQ:AMGN) 73% Return On Equity? - Yahoo Finance
Amgen Inc. $AMGN Shares Bought by Global X Japan Co. Ltd. - MarketBeat
Novo Nordisk vs. Amgen: Which Healthcare Stock Is the Smarter Choice? - The Globe and Mail
Revolve Wealth Partners LLC Sells 12,066 Shares of Amgen Inc. $AMGN - MarketBeat
Exchange Traded Concepts LLC Has $17.78 Million Position in Amgen Inc. $AMGN - MarketBeat
Is There Still Value in Amgen After Its Strong 2025 Share Price Run? - simplywall.st
Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know - sharewise.com
Amgen Stock After Hours (AMGN) on Dec. 22, 2025: FDA Clears New Prolia/Xgeva Biosimilars, Fitch Upgrades Credit — What to Know Before the Dec. 23 Open - ts2.tech
Fitch upgrades Amgen to ’BBB+’ on improved financial structure By Investing.com - Investing.com Nigeria
Fitch upgrades Amgen to ’BBB+’ on improved financial structure - Investing.com
Fitch raises Amgen credit rating, outlook stable - breakingthenews.net
Our Workforce - Amgen
Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025 - ts2.tech
Amgen’s Long-Term Pediatric Psoriasis Study on Apremilast: Why the Latest Update Matters for Investors - TipRanks
Amgen’s Pediatric Inebilizumab Study Signals Long-Term Upside in Rare Autoimmune Disease - TipRanks
Matrix Asset Advisors Inc. NY Purchases 4,633 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc (NASDAQ:AMGN) Nasdaq Index Biotechnology Leadership Focus - Kalkine Media
Amgen Inc. (NASDAQ:AMGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Amgen (AMGN) price target trimmed at Morgan Stanley as policy risks ease - MSN
Amgen (AMGN) Stock Week Ahead Forecast: Drug-Price Deal Fallout, Analyst Targets, and Year-End Catalysts to Watch (Dec. 22–26, 2025) - ts2.tech
Assessing Amgen (AMGN) Valuation After UPLIZNA Approval and New U.S. Drug Pricing Agreements - simplywall.st
The Best Dividend ETF to Buy: SCHD Pays a High Yield While VIG Focuses on Dividend Growth - The Motley Fool
Sarasin & Partners LLP Buys 47,873 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Purchased by Foster Victor Wealth Advisors LLC - MarketBeat
Signal Advisors Wealth LLC Has $867,000 Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by CHICAGO TRUST Co NA - MarketBeat
Amgen Stock (AMGN) News Today: TrumpRx Drug-Price Deal, FDA Approvals, Dividend Update, and 2026 Analyst Forecasts - ts2.tech
Voya Investment Management LLC Sells 275,398 Shares of Amgen Inc. $AMGN - MarketBeat
Bartlett & CO. Wealth Management LLC Reduces Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc (AMGN) 財務データ
収益
当期純利益
現金流量
EPS
Amgen Inc (AMGN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Grygiel Nancy A. | SVP & CCO |
Nov 20 '25 |
Sale |
337.26 |
3,139 |
1,058,667 |
7,225 |
0.58%
0.15%
大文字化:
|
ボリューム (24 時間):